Fox Business - The Power to Prosper
Search Site

Biotechnology

Tracking the hot money

BNP Paribas head of equity cash trading Darren Wolfberg breaks down where the big-money players are investing.

Read More

  1. FDA approves inhaled insulin

    Hakan Edstrom from Mannkind on the future of his company’s new product.

  2. CapEx, consumer to piggyback growth?

    South Texas Money Management president Jim Kee gives his outlook for the broader markets.

  3. Spending on pets surges

    Aratana Therapeutics CEO Steven St. Peter on what’s driving growth in the animal-health business.

  4. Should Silicon Valley get the same scrutiny as Wall Street?

    FBN’s Charles Payne, retail analyst Hitha Prabhakar, Penn Financial Group founder Matt McCall, Divine Capital CEO Dani Hughes and FOXBusiness.com reporter Kate Rogers on Silicon Valley.

  5. Alger CEO: Put new money in growth names

    Alger CEO Daniel Chung, Russell Investments chief market strategist Stephen Wood and Strategas chief investment strategist Jason Trennert give their outlooks for the markets.

  6. Is the market overdue for a correction?

    Richmond Brothers founder David Richmond, The Haverford Trust Company CIO Hank Smith and United Futures Trading Co. Senior Broker Gary Kozlowski on the outlook for stocks.

  7. CSL Limited CEO on pharma M&A, R&D spending

    CSL Limited CEO Paul Perreault and Wells Fargo senior equity strategist Scott Wren talk growth strategies.

  8. Time to buy in to Biogen Idec?

    FBN’s Charles Payne, retail analyst Hitha Prabhakar, Penn Financial Group founder Matt McCall, FBN’s Tracy Byrnes and FOXBusiness.com reporter Kate Rogers debate whether to invest in Biogen Idec.

  9. Biotechs with big goals, but no office space or full-time employees?

    Alkeus Pharmaceuticals CEO Leonide Saad on the company’s research.

  10. Making money with Illumina

    FBN’s Charles Payne on Illumina.

  11. Cornell University president: College pays off

    Cornell University president David J. Skorton weighs in on the state of education.

  12. Where to buy growth on the cheap

    RBC Capital Markets chief U.S. strategist Jonathan Golub and Wells Fargo chief portfolio strategist Brian Jacobsen give tips for asset allocation.

  1. IPO’s raised $8B in June

    FBN’s Liz MacDonald on proceeds from IPO’s.

  2. Dow hits all-time high of 17,000

    Stifel Nicolaus portfolio manager Chad Morganlander says the Dow hitting 17,000 shows the economy is on the mend.

  3. Still in a Goldilocks economy?

    Permanent Portfolio president Michael Cuggino and WSJ editor in chief Gerard Baker on the strong jobs number and where the economy is going next.

  4. Nike scoring big with the World Cup?

    Belus Capital Advisors CEO Brian Sozzi, Rosenthal Wealth Management Group President Larry Rosenthal and AverageJoeOptions.com's Todd Horwitz on the outlook for stocks.

  5. Economy eyes fifth-straight month of +200K jobs

    Glenmede director of investment strategy Jason Pride and Federated Investors chief strategist Phil Orlando give their outlook for the June employment report and the markets.

  6. GM shares up on car sales

    FBN’s Nicole Petallides breaks down the day in the markets.

  7. Inches Away From Dow 17K

    FBN’s Nicole Petallides takes a look at the markets as they approach a new record high.

‹ Prev12345Next ›
Freebase CC-BY
Source: Biotechnology on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL